Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice

data integrity 1 Minute

Our goal is to ensure that the data associated with drug manufacturing are complete, consistent, and accurate, and therefore reliable.
— Read on www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm628244.htm

Published by Jeremiah Genest

Quality professional with over 20 years of experience. Gamer and storyteller with forty years of practice.

Published

One thought on “Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice”

  1. Pingback: FDA publishes Q&A on Data Integrity – Investigations of a Dog

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.